-
Diagnostics World News | French AI startup Owkin announces big funding and Memorial Sloan Kettering Cancer Center partnership, Roche and Genentech choose Flywheel cloud informatics, and Talis Biomedical gets FDA EUA for COVID-19 test. Plus new products from VIDA Diagnostics, Oncocyte, Metabolon and more.
Nov 30, 2021
-
Diagnostics World | Illumina and Genetic Alliance announced this week the creation of the iHope Genetic Health program aimed at providing whole-genome sequencing access (WGS) to tens of thousands of patients across the globe impacted by genetic disease. At least half of iHope Genetic Health's efforts will be focused on areas of the world in need outside the US, with more than one-third of Illumina's support being dedicated to patients in Africa.
Nov 22, 2021
-
Diagnostics World News | Labs around the country with next-generation sequencing capabilities have begun using a respiratory virus panel that simultaneously tests for SARS-CoV-2 and 40 other potentially co-occurring respiratory viruses, including four cold-causing coronaviruses, both types of respiratory syncytial viruses (RSV), and more than a dozen influenza viruses.
Nov 17, 2021
-
Diagnostics World News| Geisinger researchers have been awarded a $5 million grant to develop a diagnostic tool for genetic disorders. With support from the National Institutes of Health’s National Human Genome Research Institute, the group plans to build a High Impact Phenotype Identification System. The aim is to trim the time between symptom onset and the discovery of a genetic basis to improve patient care and outcomes.
Nov 15, 2021
-
Diagnostics World News | Researchers in Germany are developing a lateral flow assay that aims to inform people if they are at heightened risk of developing Alzheimer’s disease (AD) and the robustness of their “cognitive reserve” to stave off symptoms of degenerative brain changes—all by measuring levels of three microRNAs (miRNAs) circulating in their blood.
Nov 12, 2021